supported by the Capital's Funds for Health Improvement and Research(No.2024-2-5068);the Youth Independent Innovation Project of PLA General Hospital(No.22QNCZ023);Beijing Natural Science Foundation(No.7242030);Capital Clinical Characteristic Application Research(No.Z181100001718034).
Background and aims:Currently,research on biopsy-proven acute drug-induced liver injury(DILI)remains limited.This study aimed to identify clinical characteristics and risk factors for significant hepatic inflammation ...